Advertisement
Research Article

Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature

  • Melissa C. Paoloni equal contributor,

    equal contributor Contributed equally to this work with: Melissa C. Paoloni, Anita Tandle, Chand Khanna, Steven K. Libutti

    Affiliation: Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Anita Tandle equal contributor,

    equal contributor Contributed equally to this work with: Melissa C. Paoloni, Anita Tandle, Chand Khanna, Steven K. Libutti

    Affiliation: Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Christina Mazcko,

    Affiliation: Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Engy Hanna,

    Affiliation: Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Stefan Kachala,

    Affiliation: Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Amy LeBlanc,

    Affiliation: University of Tennessee, Knoxville, Tennessee, United States of America

    X
  • Shelley Newman,

    Affiliation: University of Tennessee, Knoxville, Tennessee, United States of America

    X
  • David Vail,

    Affiliation: University of Wisconsin, Madison, Wisconsin, United States of America

    X
  • Carolyn Henry,

    Affiliation: University of Missouri, Columbia, Missouri, United States of America

    X
  • Douglas Thamm,

    Affiliation: Colorado State University, Ft. Collins, Colorado, United States of America

    X
  • Karin Sorenmo,

    Affiliation: University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Amin Hajitou,

    Affiliation: Department of Gene Therapy and Division of Medicine, Imperial College London, Wright-Flemming Institute, London, United Kingdom

    X
  • Renata Pasqualini,

    Affiliation: David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Wadih Arap,

    Affiliation: David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Chand Khanna equal contributor mail,

    equal contributor Contributed equally to this work with: Melissa C. Paoloni, Anita Tandle, Chand Khanna, Steven K. Libutti

    khannac@mail.nih.gov

    Affiliation: Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Steven K. Libutti equal contributor

    equal contributor Contributed equally to this work with: Melissa C. Paoloni, Anita Tandle, Chand Khanna, Steven K. Libutti

    Affiliation: Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Published: March 30, 2009
  • DOI: 10.1371/journal.pone.0004972

Reader Comments (0)

Post a new comment on this article